CellCo
CellCo develops biologics and biotherapies by combining synthetic biology and artificial intelligence to create medicines for complex, data-scarce biological problems. The company uses its CellOS platform to generate synthetic data and run computational models that guide biological engineering and candidate selection. Core technologies include synthetic biology, generative synthetic-data modeling, and machine learning applied to therapeutic design. CellCo operates as a deep-technology therapeutics company (B2C-facing end therapies with industry partnerships) focused on preclinical development and platform scaling. The platform is positioned to integrate with laboratory automation and partner R&D workflows to accelerate biologic discovery at scale.
CellCo
CellCo develops biologics and biotherapies by combining synthetic biology and artificial intelligence to create medicines for complex, data-scarce biological problems. The company uses its CellOS platform to generate synthetic data and run computational models that guide biological engineering and candidate selection. Core technologies include synthetic biology, generative synthetic-data modeling, and machine learning applied to therapeutic design. CellCo operates as a deep-technology therapeutics company (B2C-facing end therapies with industry partnerships) focused on preclinical development and platform scaling. The platform is positioned to integrate with laboratory automation and partner R&D workflows to accelerate biologic discovery at scale.